LATEST

We're showcasing at Venture Café London’s Thursday Gathering, "From Research Gaps to...

The AMELIE YouTube channel is home to several video interviews where you can hear from members of...

The causes and impacts of faecal incontinence are being highlighted in the latest edition of the...

Professor Charles Knowles, Clinical Chief Investigator of AMELIE Project, discusses our research...

Professor Richard Day is the Principal Investigator of the AMELIE project. He discusses how...

L'incontinence fécale (IF) est une affection courante qui touche environ 67 millions de personnes en Europe. Beaucoup de ces personnes peuvent être incontinentes à cause d'une blessure, souvent à la suite d'un accouchement. Les recherches d'AMELIE sur la médecine régénérative et la thérapie cellulaire visent à aider ces personnes. Dans le cadre du projet AMELIE, nous avons mené une enquête pour savoir ce que les gens pensent de l'IF et de la médecine régénérative dans différents pays européens.

Bowel Research UK welcomes the findings of a new report which reveals significant short-comings in the care of UK patients with pelvic floor disorders (PFDs), and provides recommendations on six areas for change to improve outcomes.

A new report, ‘Seizing the opportunity to improve patient care: Pelvic Floor services in 2021 and beyond’ exposes significant shortcomings in the care of patients with pelvic floor disorders in the UK. It provides national and local recommendations to improve healthcare services.

For millions of Britons it is a secret they dare not discuss. A problem they put up with, silently, often for decades. Incontinence will affect 40 per cent of women, and one in ten men at some point in their lives.

Fecal incontinence is a disease that affects some 67 million people in Europe. Although severity and presentation may be compatible with social life, it often overrides it entirely.

Fecal incontinence (FI) affects one in 20 Europeans. Although the severity and the way it presents itself are not life-threatening, this condition often ends up nullifying the social relationships of the people who suffer from it. And, its management continues to be a challenge for Medicine because a definitive optimal treatment for it has not yet been determined.

There are people who manage to live with it, but for most suffering fecal incontinence is synonymous with completely ending their social life, the main consequence of suffering from one of the diseases that cause the most stigma, as shown by never talking or writing about it subject.

We are happy to announce that CVBF will be involved in the new project AMELIE – Anchored Muscle cELIs for IncontinencE aimed to test a new clinical approach for the treatment of faecal incontinence (FI) arising from childbirth injury in women.